Yahoo! Finance Search - Finance Home - Yahoo! - Help

Thursday, April 24 2014 3:56am ET - U.S. Markets open in 5 hours and 34 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Biotechnology News
Latest News
Thursday, Apr 24, 2014
·Hyperion Therapeutics to Broaden Orphan Disease Pipeline With Acquisition of Andromeda Biotech Ltd.
GlobeNewswire - 26 minutes ago
·MacroGenics (MGNX) Jumps: Stock Up 7.5% - 2 hours, 33 minutes ago
·Prothena Corporation plc (PRTA) Worth Watching: Stock Rises 9.5% - Thu 12:32 am ET
Wednesday, Apr 23, 2014
·Biogen Idec's CEO Discusses Q1 2014 Earnings Results - Earnings Call Transcript
- Wed 10:54 pm ET
·Sarepta Therapeutics Announces Pricing of $100.7 Million Public Offering of Common Stock
Business Wire - Wed 9:17 pm ET
·Biotechnology Stocks To Keep on the Radar
at Investopedia - Wed 8:45 pm ET
·GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 -- GALE
GlobeNewswire - Wed 7:15 pm ET
·UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Involving IMMUNOMEDICS, INC. and Its Board of Directors and a Deadline of April 28, 2014 to Seek a Lead Plaintiff Position -- IMMU
GlobeNewswire - Wed 7:11 pm ET
·Phase 3 DECISION Trial of NEXAVAR (sorafenib) in Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Cancer Refractory to Radioactive Iodine Published in The Lancet
PR Newswire - Wed 7:02 pm ET
·Agios Pharmaceuticals 2M share Secondary priced at $44.00
- Wed 6:57 pm ET
·Agios Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Business Wire - Wed 6:56 pm ET
·Biogen Q1, Guidance Strong, But Stock Slips
at Investor's Business Daily, Inc. - Wed 6:46 pm ET
·Should You Invest in Gilead Sciences, Inc. Today?
at Motley Fool - Wed 6:32 pm ET
·3 Reasons Celgene Will Bounce Back This Year
at Motley Fool - Wed 6:32 pm ET
·Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
PR Newswire - Wed 6:30 pm ET
·Epizyme Up on Milestone Payment from Glaxo - Wed 6:10 pm ET
·Final Glance: Biotechnology companies
AP - Wed 6:04 pm ET
·Bristol-Myers, Samsung BioLogics Extend Ties - Wed 4:30 pm ET
·PTC Therapeutics to Present at Upcoming Investor Conferences
PR Newswire - Wed 4:30 pm ET
·Acceleron and Celgene Announce Interim Clinical Data for Sotatercept Demonstrating Dose Dependent Increases in Hemoglobin in Patients with End Stage Renal Disease on Hemodialysis
Business Wire - Wed 4:30 pm ET
More Latest News...
Sponsor Results
Shimadzu Life Science
A new way of thinking in the health and life science industries
Fix File Associations
Download to fix Windows 7, XP and Vista errors! (Recommended)
Lumosity Brain Games
Train memory and attention with scientific brain games.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?